Comparison of the Effect of Ranibizumab and Aflibercept on Changes in Macular Choroidal Thickness in Patients Treated for Diabetic Macular Edema.
Conclusion: In DME patients, the CSCT decreases after 5 IVI of anti-VEGF, especially after aflibercept treatment.
PMID: 32850142 [PubMed]
Source: Journal of Ophthalmology - Category: Opthalmology Tags: J Ophthalmol Source Type: research
More News: Diabetes | Diabetes Type 2 | Endocrinology | Eyes | Japan Health | Lucentis | Opthalmology | Ranibizumab Injection | Study | Vitamin A